Pharma in Focus - knowledge is power

13 - 19 May 2013

Special Report: Pharma's Budget hopes and fears
Tomorrow will see the Federal Budget handed down by a struggling minority government in an election year and in an atmosphere charged with dire predictions of revenue shortfalls and calls for generic prices on the PBS to be cut. What is pharma hoping for and fearing?

Budget that ignores PBS might best please industry
The pharma industry will be both pleased and perhaps a little nervous that the PBS has flown under the Budget radar so far in terms of speculation on significant change that will affect revenues but that doesn't mean such changes are not possible in an 'all bets are off' atmosphere

How to access Pharma in Focus articles

If you're a current subscriber, See below
If you're new to Pharma in Focus, Click here
If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Instant Update: Fri 17 May
..full report

Generics 'reeling' from PBS reform
..full report

AZ's Nexium safe till 2015
..full report

Sigma eyes pharmacy chain
..full report

CHF attacks Guild on chemo report
..full report

Appeal could delay Yasmin damages
..full report

Drug access lagging says NZ body
..full report

Quintiles IPO raises $1 billion
..full report

HPV vax prices cut for poor nations
..full report

Latest trials: Novartis controversy
..full report

Latest ARTG registrations
..full report